17 April 2020

ESMA Guidelines on performance fees in UCITS and certain types of AIFs

The European Securities and Markets Authority published its final report on the guidelines on performance fees in UCITS and certain types of AIFs on 3 April 2020 (the “Guidelines”).

The Guidelines apply to management companies of undertakings for collective Investments in transferable securities and to alternative investment fund managers that manage alternative investment funds, which are marketed to retail investors.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 17.08.2022

    GSK Update: CAA Circular 22/15: What is new for the governance of insurance and reinsurance companies

    Read more
  • 10.02.2022

    GSK Update: Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

    Read more
  • 27.01.2022

    GSK Update: CSSF Guidance on Virtual Assets: New FAQ for UCI and credit institutions

    Read more
Contact person

Dr. Marcus Peter, LL.M.

Partner

+352 271802-50

marcus.peter@gsk-lux.com

Corinna Schumacher, LL.M.

Senior Associate

+352 271802-81

corinna.schumacher@gsk-lux.com

© GSK Stockmann 2022